Browse diseases

…Introduction Chronic management of Inflammatory Bowel Disease (IBD) in the NHS has traditionally relied on routine, time-base…

…Introduction In PREdiCCt, the largest prospective study of IBD flare, female sex was strongly associated with increased patien…

…e with a mean age of diagnosis of 32.7 (SD 16) years. 49.1% had ulcerative colitis (n = 1991), 46.5% Crohn’s disease (n = 1889) and 4.4% IBD-U (n …

… Among 259 patients (53% male, median age 63), cancers included melanoma (43%), renal (19%), lung (16%) and others. ICI regimens include…

…ekinumab is an effective treatment for Crohn’s disease (CD) and ulcerative colitis (UC). The advent of biosimilar ustekinumab in 2024 and potentia…

… high-risk features, one (0.5%) was subsequently diagnosed with Crohn’s disease at 18 months.Conclusion This audit demonstrates poor adherence …

…s-subspecialty (16/681; 2%). A total of 97 diagnoses were made. Cirrhosis was the most common 102/681 (14.9%) followed by Inflammatory bo…

…primary outcome was significant bowel disease (SBD), defined as colorectal cancer (CRC), inflammatory bowel disease (IBD), or high-risk polyps (H…

…suspected or known inflammatory bowel disease (IBD) (51.5%) and iron-deficiency anaemia (25.0%). Bowel preparation was adequate in 89.4%, examinations …

…the safety of advanced combination therapy (ACT) in adults with inflammatory bowel disease (IBD), with secondary exploratory evaluation of efficacy outcom…

…s, metabolic dysfunction-associated steatotic liver disease and atherosclerotic cardiovascular disease, are increasingly prevalent among individuals with inflammatory…

…nvolved, and their differences between Crohn’s disease (CD) and ulcerative colitis (UC), the two main subtypes of IBD remain unclear.Objective To …